Deton Corp delivers medical device solutions to healthcare providers by combining innovations in both engineering and medicine. Founded in 2009 by Patrick Sislian, Ph.D. and Ramzi Nasr, Ph.D., Deton Corp has patent-pending technology that identifies respiratory diseases such as Tuberculosis and Pneumonia.
Respiratory diseases are responsible for more than 2 million deaths worldwide each year. Most of these deaths can be prevented when the patient is accurately diagnosed. Diagnosis is the first step to receiving proper treatment. Deton Corp is committed to developing medical device solutions that will enable healthcare providers to correctly diagnose respiratory diseases and ultimately save their patient's lives.